Lipid peroxidation and the response of the antioxidant defense system in the obese type 2 diabetic compared with the non-obese type 2 diabetic;peroxidación de lípidos y la respuesta del sistema de defensa antioxidante en el diabético tipo 2 obeso en comparación al diabético tipo 2 sin obesidad

Nutricion Hospitalaria

Volumn 28, Issue 6, 2013, Pages 1905-1911

  Gaxiola Robles, Ramón ^a,b   Bitzer Quintero, Oscar Kurt ^c   Méndez Rodríguez, Lía Celina ^a   Labrada Martagón, Vanessa ^a   García González, Adolfo ^b   Ramírez Jirano, Luis Javier ^c   Veléz Alavez, Marcela ^a   Zenteno Savín, Tania ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS DEL NOROESTE   (Mexico)

^b Hospital General de Zona IMSS   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Antioxidants; Diabetes mellitus type 2; Lipid peroxides; Obesity; Oxidative stress

Indexed keywords

ANTIOXIDANT; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; BODY MASS; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

ADULT; ANTIOXIDANTS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; OBESITY; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84891665800     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2013.28.6.6946     Document Type: Article

References (25)

1. Stefanovic A, Kotur-Stevuljevic J, Spasic S, Bogavac-Stanojevic N, Bujisic N. The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients. Diabetes Res Clin Pract 2008; 79: 156-163.
2. Chaia Kaippert V, Kimi Uehara S, Lima D'Andrea C et al. Influence of the body mass and visceral adiposity on glucose metabolism in obese women with Pro12Pro genotype in PPARgamma2 gene. Nutrición Hospitalaria 2013; 28: 694-700.
3. Berrington de Gonzalez A, Hartge P, Cerhan JR et al. Bodymass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211-2219.
4. Valdecantos MO, Perez-Matute P, Martinez JA. Obesidad y estrés oxidativo: papel de la suplementación con antioxidantes de la dieta. Rev Inv Clinica 2012; 61: 127-139.
5. Lau YS, Tian XY, Huang Y, Murugan D, Achike FI, Mustafa MR. Boldine protects endothelial function in hyperglycemiainduced oxidative stress through an antioxidant mechanism. Biochem Pharmacol 2013; 85: 367-375.
6. De Tursi Ríspoli L, Vazquez Tarragón A, Vazquez Prado A, Sáez Tormo G, Mahmoud Ismail A, Gumbau Puchol V. Estrés oxidativo; estudio comparativo entre un grupo de población normal y un grupo de población obesa mórbida. Nutricion Hospitalaria 2013; 28: 671-675.
7. Turk HM, Sevinc A, Camci C et al. Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Acta Diabetol 2002; 39: 117-122.
8. Abraira C, Emanuele N, Colwell J et al. Glycemic control and complications in type II diabetes. Design of a feasibility trial. VA CS Group (CSDM). Diabetes Care 1992; 15: 1560-1571.
9. Reddy SC, Kihn YM, Nurjahan MI, Ramil A. Retinopathy in type 2 diabetic patients with microalbuminuria. Nepal J Ophthalmol 2013; 5: 69-74.
10. Vinik AI, Vinik E. Prevention of the complications of diabetes. Am J Manag Care 2003; 9: S63-S80; quiz S81-4.
11. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
12. Díaz Arce D. Hiperglicemia y estrés oxidativo en el paciente diabético. Rev Cubana Invest Bioméd 2006; 25.
13. Tucci S, Flogel U, Sturm M, Borsch E, Spiekerkoetter U. Disrupted fat distribution and composition due to mediumchain triglycerides in mice with a beta-oxidation defect. Am J Clin Nutr 2011; 94:439-449.
14. Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int J Obes Relat Metab Disord 2002; 26: 1159-1164.
15. Murphy MP. How mitochondria produce reactive oxygen species. Biochem J 2009; 417: 1-13.
16. Tang J, Yan H, Zhuang S. Inflammation and oxidative stress in obesity-related glomerulopathy. Int J Nephrol 2012; 2012: 608397.
17. Oviedo-Mota MA, Espinosa-Larrañaga F, Reyes-Morales H, Trejo-Pérez JA, Gil Velázquez E. Guía clínica para el diagnóstico y tratamiento de la diabetes mellitus tipo 2. Rev Med IMSS 2003; 41:S27-S46. Disponible en: http://www.medigraphic. com/pdfs/imss/im-2003/ims031d.pdf
18. Zenteno-Savin T, Clayton-Hernandez E, Elsner R. Diving seals: are they a model for coping with oxidative stress? Comp Biochem Physiol C Toxicol Pharmacol 2002; 133: 527-36.
19. Suzuki K. Measurement Of Mn-Sod And Cu, Zn-Sod. In: Taniguchi N. Gutteridge J. (Eds.) Experimental Protocols For Reactive Oxygen And Nitrogen Species. Oxford University Press. U. K. 2000. pp. 91-95.
20. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
21. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1984; 105: 114-121.
22. Katz MH. Applied regression analysis and other multivariable methods. Cambridge University press. Second edition, United States of America 2006.
23. Varashree BS, Bhat GP. Correlation of Lipid Peroxidation with Glycated Haemoglobin Levels in Diabetes Mellitus. Online Journal of Health and Allied Sciences, 2011, vol. 10, no 2. http://cogprints.org/7968/
24. Codoner-Franch P, Valls-Belles V, Arilla-Codoner A, Alonso-Iglesias E. Oxidant mechanisms in childhood obesity: the link between inflammation and oxidative stress. Transl Res 2011; 158: 369-384.
25. Olczyk K, Koscielniak-Kocurek E, Sonecki P, Zdenkowski W. The lipid peroxidation products and the enzymes of antioxidant system in patients with diabetes mellitus. Rocz Akad Med Bialymst 1994; 39: 93-99.